Search Results

Your search for Lawrence H. Einhorn, MD matches 2 pages

Showing 1 - 2

By Matthew Stenger / Tuesday, April 24, 2018 2:13 PM

Morbidity in Testicular Cancer Survivors Treated With Standard Cisplatin-Based Chemotherapy

In a study reported in the Journal of Clinical Oncology, Kerns et al found that approximately 20% of testicular cancer survivors treated with cisplatin-based regimens had high cumulative burden of morbidity (CBM) scores and identified factors associated with risk for increased morbidity. Study...

solid tumors

By The ASCO Post Staff / 2017 Genitourinary Cancers Symposium

Lawrence H. Einhorn, MD, on Testicular Cancer: The Keynote Lecture

Lawrence H. Einhorn, MD, of the Indiana University Simon Cancer Center, summarizes his keynote lecture on the controversies in management of clinical stage I testicular cancer and the long-term consequences of platinum combination chemotherapy.

Apr

Today In Oncology

Search Results

Your search for Lawrence H. Einhorn, MD matches 2 pages

Morbidity in Testicular Cancer Survivors Treated With Standard Cisplatin-Based Chemotherapy

Lawrence H. Einhorn, MD, on Testicular Cancer: The Keynote Lecture

Adagrasib Plus Cetuximab in KRAS G12C–Mutated Colorectal Cancer

Induction and Concurrent Vismodegib With Radiation Therapy for Locally Advanced Unresectable Basal Cell Carcinoma

FDA Approves Nogapendekin Alfa Inbakicept-pmln for BCG-Unresponsive Non–Muscle Invasive Bladder Cancer

Predicting Ovarian Cancer Relapse With Spatial Tissue Analysis

Chemohormonal Therapy for Locally Advanced Prostate Cancer